The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Prior Hospitalization for Epilepsy, Diabetes, and Stroke and Subsequent Glioma and Meningioma Risk
Abstract
We conducted a case-control study to evaluate the preclinical association between epilepsy, diabetes, and stroke and primary adult brain tumors. We first identified all 1,501 low-grade glioma, 4,587 high-grade glioma (HGG), and 4,193 meningioma cases reported to the Swedish Cancer Registry from 1987 to 1999. Next, controls (137,485) were randomly selected from the continuously updated Swedish Population Registry and matched to cases diagnosed that year on age and sex. Finally, cases and controls were linked to the Swedish Hospital Discharge Registry (1969-1999). We found that ≥8 years before HGG diagnosis (or control reference year) there was an elevated risk of HGG among people discharged with epilepsy [odds ratio (OR), 3.01; 95% confidence interval (95% CI), 1.73-5.22]. Two to 3 years before HGG diagnosis, this risk increased (OR, 5.33; 95% CI, 3.58-7.93) and was especially strong among people ages <55 years (OR, 13.49; 95% CI, 6.99-25.94). During this 2- to 3-year prediagnostic period, we also found an increased risk of HGG among people discharged with meningitis (OR, 3.02; 95% CI, 1.06-8.59) or viral encephalitis (OR, 12.64; 95% CI, 2.24-71.24). Results are similar for glioblastoma multiforme, low-grade glioma, and meningioma. In contrast, risk of HGG among people discharged with diabetes or stroke does not increase until year of brain tumor diagnosis. The occurrence of excess epilepsy ≥8 years before HGG diagnosis suggests a relatively long preclinical phase, but excess diabetes or stroke appear late in HGG development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Actually, in one Swedish study investigating the preclinical association between mobile phone use and primary adult intracranial tumours (Schwartzbaum et al., 2005), an increased risk of meningioma was observed among people discharged with epilepsy ≥ 11 years before the neoplasm diagnosis (OR 2.16; 95 % CI 1.45–3.21).”
From The effect of exposure to radiofrequency fields on cancer risk in the general and working population: A systematic review of human observational studies - Part I: Most researched outcomes. (2024) · cites this paper as Schwartzbaum et al., 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wideroff, L., Gridley, G., Chow, W. H., Linet, M., Mellemkjaer, L., Olsen, J. H., Keehn, S., & Borch-Johnsen, K. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.18.1360 · Cited by 627 · cited 2×
“In contrast to the positive association with epilepsy and glioma, an inverse association between diabetes and glioma has been observed previously in two studies (7, 8) but not in four others (1, 9-11).”
BackgroundResult
Research works printed but not linked: 26
- Schlehofer B, Blettner M, Preston-Martin S, et al. Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 1999;82:155–60. · DOI
- Olsen JH, Boice JD Jr, Jensen JP, Fraumeni JF Jr. Cancer among epileptic patients exposed to anticonvulsant drugs. J Natl Cancer Inst 1989;81:803–8. · DOI
- Lamminpaa A, Pukkala E, Teppo L, Neuvonen PJ. Cancer incidence among patients using antiepileptic drugs: a long-term follow-up of 28,000 patients. Eur J Clin Pharmacol 2002;58:137–41. · DOI
- Shirts SB, Annegers JF, Hauser WA, Kurland LT. Cancer incidence in a cohort of patients with seizure disorders. J Natl Cancer Inst 1986;77:83–7.
- Inskip PD. Etiology of brain tumors in adults. Epidemiol Rev 1995;17:382–414. · DOI
- Schwartzbaum J, Jonsson F, Ahlbom A, et al. Cohort studies of association between self-reported allergic conditions, immune-related diagnoses and glioma and meningioma risk. Int J Cancer 2003;106:423–8. · DOI
- Aronson SM, Aronson BE. Central nervous system in diabetes mellitus. Lowered frequency in certain intracranial malignancies. Arch Neurol 1965;12:390–8. · DOI
- Brenner AV, Linet MS, Fine HA, et al. History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer 2002;99:252–9. · DOI
- Mills PK, Preston-Martin S, Annegers JF. Risk factors for tumors of the brain and cranial meninges in Seventh Day Adventists. Neuroepidemiology 1989;8:266–75. · DOI
- Cicuttini FM, Hurley SF, Forbes A. Association of adult glioma with medical conditions, family, and reproductive history. Int J Cancer 1997;71:203–7. · DOI
- Schlehofer B, Blettner M, Becker N, Martinsohn C, Wahrendorf J. Medical risk factors and the development of brain tumors. Cancer 1992;69:2541–7. · DOI
- Wrensch M, Weinberg A, Wiencke J, Miike R, Barger G, Kelsey K. Prevalence of antibodies to four herpesviruses among adults with glioma and controls. Am J Epidemiol 2001;154:161–5. · DOI
- Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro-oncol 2002;4:278–99. · DOI
- Wiemels JL, Wiencke JK, Sison JD, Miike R, McMillan A, Wrensch M. History of allergies among adults with glioma and controls. Int J Cancer 2002;98:609–15. · DOI
- Lonn S, Klaeboe L, Hall P, et al. Incidence trends of adult primary intracerebral tumors in four Nordic countries. Int J Cancer 2004;108:450–5. · DOI
- Rothman K, Greenland S. Modern epidemiology. Philadelphia: Lippincott-Raven; 1998.
- Behin A, Hoang-Xuan K, Carpentier AF, Delattre J-Y. Primary brain tumors in adults. Lancet 2003;361:323–31. · DOI
- Kleihues P, Ohgaki H. Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro-oncol 1999;1:44–51. · DOI
- Nilsson A, Spetz C, Carsjo K, Nightingale R, Smedby B. Reliability of the hospital registry. The diagnostic data are better than their reputation. Lakartidningen 1994;91:603–5.
- Pignatti F, van den Bent M, Curran D, et al. Prognostic factors from survival in adult patients with cerebral low-grade glioma. J Clin Oncol 2002;20:2076–84. · DOI
- Lote K, Stenwig AE, Skullerud K, Hirschberg H. Prevalence and prognostic significance of epilepsy in patients with gliomas. Eur J Cancer 1998;34:98–102. · DOI
- Duffau H, Capelle L. Preferential brain locations of low-grade gliomas. Cancer 2004;100:2622–6. · DOI
- Schaller B, Ruegg B. Brain tumor and seizures: pathophysiology and its implications for treatment revisited. Epilepsia 2003;44:1223–32. · DOI
- Landy HJ, Lee TT, Potter P, Feun L, Markoe A. Early MRI findings in high grade glioma. J Neurooncol 2000;47:65–72. · DOI
- Morgenstern L, Frankowski R. Brain tumor masquerading as stroke. J Neurooncol 1999;44:47–52. · DOI
- Sawaya R, Ramo OJ. Systemic and thromboembolic effects of eningiomas. In: Al-Mefty O, editor. Meningiomas. New York: Raven Press, Ltd.; 1991. p. 137–44.
Cited by
Sorted by citations
Karipidis, K., Baaken, D., Loney, T., Blettner, M., Brzozek, C., Elwood, M., Narh, C., Orsini, N., Röösli, M., Paulo, M. S., et al. (2024) · Environment International · doi:10.1016/j.envint.2024.108983 · Cited by 58
Metadata
- Authors
- Schwartzbaum, J., Jonsson, F., Ahlbom, A., Preston-Martin, S., Malmer, B., Lönn, S., Söderberg, K., & Feychting, M.
- Affiliations
- 1Division of Epidemiology and Biometrics, School of Public Health, Ohio State University, Columbus, Ohio;
- 2Division of Epidemiology, Institute for Environmental Medicine, Karolinska Institutet, Stockholm, Sweden;
- 3University of Southern California School of Medicine, Los Angeles, California; and
- 4Department of Radiation Sciences, Oncology, Umeå University Hospital, Umeå, Sweden
- Venue
- Cancer Epidemiology, Biomarkers & Prevention
- Published
- 2005-03-01
- Volume
- 14
- Issue
- 3
- Pages
- 643-650
- ISSN
- 1055-9965
- 1538-7755
- Cited by
- 56
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
